Has Meisam Moghbelli, MD received payments from drug or device companies?

Yes. Drug and device makers reported $173,066 in general payments to Meisam Moghbelli, MD across 303 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meisam Moghbelli, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meisam Moghbelli, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meisam Moghbelli, MD

Cardiovascular Disease · Madison, WINPI 1790827210

Payments from drug & device makers

$173,066in general payments, 2019–2025

Across 303 payments — averaging $571.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim Pharma GmbH & Co.kg$160K
Boehringer Ingelheim International GmbH$6K
Abbott$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
Pfizer$580
Novartis$530
plus $4K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim Pharma GmbH & Co.kg	18	$159,603
Boehringer Ingelheim International GmbH	33	$6,337
Abbott	13	$1,239
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	53	$1,153
Pfizer	30	$580
Novartis	25	$530
Boston Scientific	7	$432
Johnson & Johnson(2 entities)	19	$297
E.r. Squibb & Sons, L.L.C.	16	$268
Abiomed	3	$268
Amgen	15	$242
Vifor Pharma, Inc.	2	$220
Edwards Lifesciences	2	$174
Paragonix Technologies, Inc.	3	$160
AstraZeneca	3	$152
United Therapeutics Corporation	6	$144
Boehringer Ingelheim	7	$144
Impulse Dynamics (USA) Inc.	2	$142
Merck	5	$106
Lexicon Pharmaceuticals, Inc.	5	$101
Medtronic(2 entities)	3	$96
Novo Nordisk	4	$82
Kestra Medical Technology Services, Inc.	4	$63
Alnylam Pharmaceuticals Inc.	2	$54
Lantheus Medical Imaging, Inc.	2	$53
Sanofi	2	$40
Atricure, Inc.	2	$37
Bayer	2	$36
Esperion Therapeutics, Inc.	2	$36
Kls-martin L.p.	2	$36
BD	1	$35
Kiniksa Pharmaceuticals International, PLC	2	$34
Chiesi USA, Inc.	1	$29
Cvrx, Inc.	1	$29
Lundbeck LLC	1	$24
Sanofi-aventis U.S. LLC	1	$23
Baxter Healthcare	1	$19
Actelion Pharmaceuticals US, Inc.	1	$19
Pacira Pharmaceuticals Incorporated	1	$17
Takeda Pharmaceuticals U.S.A., Inc.	1	$15

How this compares

$173,066 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.

See all cardiovascular disease providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$377,818

Medicare patients

4,652

Services billed

8,814

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Madison

Paul HinderakerMadison$463K
David PhamMadison$425K
Farhan RazaMadison$359K
Peter MasonMadison$274K
David SloskyMadison$247K
Peter RahkoMadison$122K
Peter MarogilMadison$64K
Matthew TattersallMadison$56K
Abraham JacobMadison$50K
Peter LeeMadison$48K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →